U.S. Markets open in 6 hrs, 14 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,384.21 | 152.25 | 1.36% |
| NASDAQ | 2,294.44 | 51.12 | 2.28% |
| S&P 500 | 1,273.70 | 21.39 | 1.71% |
| Day Low 09:42 AM EDT | 43.46 | |
|---|---|---|
| Day High 02:59 PM EDT | 45.055 |
|
| Range | 1.59 | |
| Volume | 17.52 M | |
| 30-Day Avg. Vol. | 6.56 M |
|
| Difference | 167.18% | |
| Market Cap. | 36.54 B | |
| Change | 1.48 B | |
| Shares Out. | 812 M | |
| Percent Traded | 2.16% | |
| Revenue | 9.4 B | |
| Earnings | 1.95 B | |
| EPS (TTM) | 2.54 |
| 52-Wk Low 8/16/07 | 40.16 | |
|---|---|---|
| 52-Wk High 2/27/08 | 50.00 |
|
| Range | 9.84 | |
| Prev. Close 7/7/08 | 43.18 | |
| Today's Open | 43.59 | |
| Change | 0.95% | |
| Dividend (TTM) | 0.45265 | |
| Div. Yield (TTM) | 0.96% |
|
| Beta | 0.3298 | |
| P/E Ratio (TTM) | 17.31 | |
| P/E Ratio (Fwd.) | 16.00 |
The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA, the company makes generic versions of brand-name antibiotics, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.656 12/31/07 | 0.69 12/31/07 |
0.034
Beat
|
| Last Quarter | 0.632 3/31/08 | 0.64 3/31/08 |
0.008
Beat
|
| Quarterly - 12/31/2007 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 2.71 B | 9.41 B |
| Gross Profit | 1.42 B | 4.88 B |
| Operating Income | 695.72 M | 2.40 B |
| Net Income | 599.94 M | 1.95 B |
